InvestorsHub Logo
Followers 10
Posts 174
Boards Moderated 0
Alias Born 10/30/2020

Re: None

Thursday, 05/06/2021 12:07:23 AM

Thursday, May 06, 2021 12:07:23 AM

Post# of 198961
As per PR 4/19:

Monoclonal Antibodies for Treatment of HIV Milestones

1st Milestone: Testing of anti-HIV Monoclonal Antibodies at University of Montana

Status: in process. Time to completion: 1 month (we are 14 days away but of course things can be delayed)

ITV-1 anti-HIV Therapeutics:

We will have a definitive timeline for the expected date of initiation and completion of clinical trials in the coming weeks.


Then we have the uplist to OTCQB which should happen very soon.

Plus this - late spring (that’s soon IMO):

Additionally, the Company has entered negotiations with Pro Wave Ad Product ("PWA"), a Bulgarian Company, to supply the raw material for PWA's Contract in India for the production of a spray modulating the immune system under U.S. Patent No. 8,309,072 owned by Zhabilov Trust. This contract is valued at more than $50 million to PWA. This is the only approved use of this technology as a nutraceutical. The FDA issued a nutraceutical number to Harry Zhabilov on October 12, 2018. The first delivery under this agreement with PWA is expected to be in late spring 2021. The value to the Company is yet to be determined.